P. Waters

发表

Glutamate receptor δ2 serum antibodies in pediatric opsoclonus myoclonus ataxia syndrome

A. Vincent, R. Fischer, S. Irani, 2018, Neurology.

Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis

S. Irani, Jae-Won Hyun, Su-Hyun Kim, 2018, Multiple sclerosis.

Mutational Analyses of the Recombinant Globular Regions of Human C1q A, B, and C Chains Suggest an Essential Role for Arginine and Histidine Residues in the C1q-IgG Interaction1

B. Atanasov, M. Gadjeva, Robert B Sim, 2004, The Journal of Immunology.

The clinical profile of NMOSD in Australia and New Zealand

K. Dear, S. Broadley, J. Lechner-Scott, 2020, Journal of Neurology.

Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain

M. Papadopoulos, S. Saadoun, J. Bennett, 2014, Acta neuropathologica communications.

Myasthenia gravis and neuromyelitis optica spectrum disorder

Jacqueline Palace, R. Howard, J. Palace, 2012, Neurology.

Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica

Anne-Kathrin Kienzler, Jacqueline A Palace, S. Irani, 2018, Brain : a journal of neurology.

N‐methyl‐D‐aspartate receptor antibody production from germinal center reactions: Therapeutic implications

Darren J. Fowler, Anne-Kathrin Kienzler, B. Lennox, 2018, Annals of neurology.

LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes

C. Klein, S. Irani, S. Pittock, 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.

K. Fujihara, Jacqueline A Palace, T. Misu, 2012, Brain : a journal of neurology.

Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-up

G. Plant, B. Weinshenker, Z. Khaleeli, 2019, Journal of Neurology, Neurosurgery, and Psychiatry.

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

A. Traboulsee, B. Banwell, W. Carroll, 2015, Neurology.

Seizures and Encephalitis in Myelin Oligodendrocyte Glycoprotein IgG Disease vs Aquaporin 4 IgG Disease

M. Duddy, R. Appleton, T. Solomon, 2018, JAMA neurology.

Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients

A. Vincent, S. Irani, M. Mané-Damas, 2019, JCI insight.

Isolation and characterization of rare circulating autoantibody-producing cells from patients with muscle-specific kinase myasthenia gravis

A. Vincent, S. Irani, M. Mané-Damas, 2018, bioRxiv.

IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG

A. Vincent, J. Cossins, M. Maestri, 2017, Neurology: Neuroimmunology & Neuroinflammation.

Compromised fidelity of B‐cell tolerance checkpoints in AChR and MuSK myasthenia gravis

Jason A. Vander Heiden, A. Vincent, R. Barohn, 2016, Annals of clinical and translational neurology.

MuSK Myasthenia Gravis IgG4 Disrupts the Interaction of LRP4 with MuSK but Both IgG4 and IgG1-3 Can Disperse Preformed Agrin-Independent AChR Clusters

A. Vincent, J. Cossins, D. Beeson, 2013, PloS one.

Antibodies identified by cell‐based assays in myasthenia gravis and associated diseases

A. Vincent, J. Cossins, D. Beeson, 2012, Annals of the New York Academy of Sciences.

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

K. Fujihara, T. Misu, M. Aoki, 2014, Neurology.

Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays.

A. Vincent, P. Waters, A. Vincent, 2008, International MS journal.

Mechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica

F. Paul, F. Zipp, R. Hohlfeld, 2008, Nature Clinical Practice Neurology.

Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica

M. Esiri, J. Palace, A. Weir, 2009, Journal of Neurology, Neurosurgery, and Psychiatry.

Erratum to: Absence of aquaporin-4 antibodies in patients with idiopathic intracranial hypertension

B. Sharrack, A. Vincent, P. Waters, 2010, Journal of Neurology.

Absence of aquaporin-4 antibodies in patients with idiopathic intracranial hypertension

B. Sharrack, A. Vincent, P. Waters, 2010, Journal of Neurology.

Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes

A. Vincent, U. Sheerin, H. Meinck, 2014, Brain : a journal of neurology.

Antibodies Against Hypocretin Receptor 2 Are Rare in Narcolepsy

G. Plazzi, A. Vincent, F. Pizza, 2017, Sleep.

Refining cell-based assay to detect MOG-IgG in patients with central nervous system inflammatory diseases.

S. Y. Kim, S. Irani, Yeseul Kim, 2020, Multiple sclerosis and related disorders.

Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation

S. Broadley, J. Lechner-Scott, M. Slee, 2020, Frontiers in Neurology.

Serial Anti–Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes

D. Arnold, A. Bar-Or, B. Banwell, 2019, JAMA neurology.

Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies

Seong-Joon Kim, S. Irani, Sung-Min Kim, 2018, Journal of Neuroinflammation.

Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases

S. Irani, Yeseul Kim, Gayoung Kim, 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease

E. Schiffer, Jacqueline A Palace, N. Sibson, 2017, Acta neuropathologica communications.

Clinical presentation and prognosis in MOG-antibody disease: a UK study

Jacqueline Palace, A. Vincent, A. Roca-Fernández, 2017, Brain : a journal of neurology.

Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis

C. Serguera, P. Horellou, K. Deiva, 2015, Journal of Neuroimmunology.

Aquaporin-4 antibody–positive cases beyond current diagnostic criteria for NMO spectrum disorders

Y. Itoyama, K. Fujihara, T. Misu, 2013, Neurology.

Antibodies to GABAA receptor &agr;1 and &ggr;2 subunits: Clinical and serologic characterization

A. Vincent, J. Coebergh, S. Irani, 2015 .

Absence of Neuronal Autoantibodies in Neuropsychiatric Systemic Lupus Erythematosus

F. Piehl, D. Duffy, S. Irani, 2020, Annals of neurology.

Neuromyelitis optica relapses: Race and rate, immunosuppression and impairment.

Jacqueline Palace, E. Wassmer, M. Leite, 2016, Multiple sclerosis and related disorders.

C 1 q-IgG Interaction Arginine and Histidine Residues in the Chains Suggest an Essential Role for Globular Regions of Human C 1 q A , B , and C Mutational Analyses of the Recombinant and Uday

B. Atanasov, M. Gadjeva, Robert B Sim, 2004 .

Antiglycine-receptor encephalomyelitis with rigidity

A. Vincent, A. Saiz, M. Leite, 2010, Journal of Neurology, Neurosurgery & Psychiatry.

The autoantibody-mediated encephalitides: from clinical observations to molecular pathogenesis

S. Irani, S. Ramanathan, P. Waters, 2019, Journal of Neurology.

Morvan syndrome: Clinical and serological observations in 29 cases

A. Vincent, K. Kleopa, S. Irani, 2012, Annals of neurology.

Glutamate receptor delta2 serum antibodies in paediatric opsoclonus myoclonus ataxia syndrome

A. Vincent, R. Fischer, S. Irani, 2018 .

Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis

Jacqueline A Palace, A. Vincent, R. Geraldes, 2017, Brain : a journal of neurology.

Detection methods for neural autoantibodies.

B. Lang, P. Pettingill, P. Waters, 2016, Handbook of clinical neurology.

Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2

S. Irani, P. Waters, S. Michael, 2020, Practical Neurology.

Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies With Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia

A. Vincent, K. Arimura, S. Irani, 2018, JAMA neurology.

Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies

A. Vincent, J. Adcock, S. Irani, 2017, Journal of Neurology, Neurosurgery & Psychiatry.

Low Levels of Vitamin D in Neuromyelitis Optica Spectrum Disorder: Association with Disease Disability

A. Vincent, Soo-Youn Lee, Sook-Young Woo, 2014, PloS one.

Autoantibodies in Japanese patients with ocular myasthenia gravis

A. Vincent, S. Irani, L. Jacobson, 2020, Muscle & nerve.

Update on biomarkers in neuromyelitis optica

J. P. Garrahan, Terry J. Smith, Jacqueline Palace, 2015, Neurology: Neuroimmunology & Neuroinflammation.

Reduction in Serum Aquaporin-4 Antibody Titers During Development of a Tumor-Like Brain Lesion in a Patient With Neuromyelitis Optica: A Serum Antibody–Consuming Effect?

H. Budka, H. Lassmann, A. Vincent, 2015, Journal of neuropathology and experimental neurology.

Neuromyelitis Optica IgG Causes Placental Inflammation and Fetal Death

M. Papadopoulos, S. Saadoun, J. Bennett, 2013, The Journal of Immunology.

Inflammation and Fetal Death Neuromyelitis Optica IgG Causes Placental

M. Papadopoulos, S. Saadoun, A. Vincent, 2013 .

T cell deficiency does not reduce lesions in mice produced by intracerebral injection of NMO-IgG and complement

M. Papadopoulos, A. Verkman, S. Saadoun, 2011, Journal of Neuroimmunology.

Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients

A. Vincent, N. Yesilot, G. Akman-Demir, 2011, Journal of Neurology.

Peripherally derived macrophages as major phagocytes in MOG encephalomyelitis

J. Sung, Sung-Hye Park, Sung-Min Kim, 2019, Neurology: Neuroimmunology & Neuroinflammation.

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype

Jacqueline A Palace, A. Vincent, M. Leite, 2012, Neurology.

Antibodies to aquaporin-1 are not present in neuromyelitis optica

S. Vukusic, Jacqueline A Palace, M. Reindl, 2015, Neurology: Neuroimmunology & Neuroinflammation.

Neuroimaging in Aicardi-Goutières syndrome

Joseph M. Nour, M. Nour, Jacqueline Palace, 2016, Neurology.

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.

Jacqueline A Palace, A. Vincent, M. Leite, 2014, JAMA neurology.

Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitis

Joshua A. Bull, David W. Nauen, D. Quested, 2022, Brain : a journal of neurology.

Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapy

S. Kleinstein, C. Watson, K. Hoehn, 2022, Acta Neuropathologica Communications.

Surfactant proteins SP-A and SP-D: structure, function and receptors.

M. Kamran, K. Reid, T. Chakraborty, 2006, Molecular immunology.

Purification of native surfactant protein SP-A from pooled amniotic fluid and bronchoalveolar lavage.

U. Kishore, A. G. Tsolaki, P. Waters, 2014, Methods in molecular biology.

Lung surfactant proteins A and D as pattern recognition proteins.

U. Kishore, M. Vaid, P. Waters, 2009, Advances in experimental medicine and biology.

Therapeutic effects of recombinant forms of full-length and truncated human surfactant protein D in a murine model of invasive pulmonary aspergillosis.

U. Kishore, E. Crouch, V. Singh, 2009, Molecular immunology.

GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction

Anne de Saint Martin, N. Burnashev, T. Tsintsadze, 2013, Nature Genetics.

NMDA receptor antibodies associated with distinct white matter syndromes

A. Vincent, A. Siddiqui, Jean-Pierre Lin, 2014, Neurology: Neuroimmunology & Neuroinflammation.

Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features

Jacqueline A Palace, R. Appleton, A. Vincent, 2014, Journal of Neurology, Neurosurgery & Psychiatry.

Case Report: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Relapse With COVID-19

James W. Mitchell, P. Waters, S. Huda, 2020, Frontiers in Neurology.

Antibodies against hypocretin receptor 2 are rare in narcolepsy.

G. Plazzi, A. Vincent, F. Pizza, 2016, Sleep.

Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies.

Jacqueline A Palace, A. Vincent, M. Leite, 2013, JAMA neurology.

International multicenter examination of MOG antibody assays

Jacqueline Palace, K. Rostásy, J. Mills, 2020, Neurology: Neuroimmunology & Neuroinflammation.

Protective effects of a recombinant fragment of human surfactant protein D in a murine model of pulmonary hypersensitivity induced by dust mite allergens.

U. Kishore, S. Parida, P. Waters, 2003, Immunology letters.

Serologic diagnosis of NMO

Jacqueline Palace, A. Bar-Or, J. Mandrekar, 2012, Neurology.

Autoantibodies to glutamic acid decarboxylase in patients with epilepsy and their relationship with type 1 diabetes: a pilot study

S. Howell, A. Vincent, I. Idris, 2015, Journal of Neurology, Neurosurgery & Psychiatry.

PROGRESSIVE ENCEPHALOMYELITIS, RIGIDITY, AND MYOCLONUS: A NOVEL GLYCINE RECEPTOR ANTIBODY

Michael K. Hutchinson, M. Hutchinson, C. Becker, 2008, Neurology.

Acute Measles Encephalitis in Partially Vaccinated Adults

N. V. Trung, P. Horby, H. Wertheim, 2013, PloS one.

Symptomatic brain involvement as the initial manifestation of neuromyelitis optica

Dong Kyoo Lee, A. Vincent, B. Kim, 2013, Journal of Clinical Neuroscience.

Sjögren’s syndrome myelopathy: spinal cord involvement in Sjögren’s syndrome might be a manifestation of neuromyelitis optica

Yoon-Ho Hong, J. Sung, K. Park, 2009, Multiple sclerosis.

Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica

A. Vincent, B. Kim, P. Waters, 2009, Multiple sclerosis.

Detection of MOG-IgG by cell-based assay: moving from discovery to clinical practice

D. Sato, P. Waters, M. Woodhall, 2020, Neurological Sciences.

Neuronal Antibodies in Children with or without Narcolepsy following H1N1-AS03 Vaccination

M. Partinen, A. Vincent, A. Pollard, 2015, PloS one.

Neuronal Antibodies in Children with or without Narcolepsy following H 1 N 1-AS 03 Vaccination Thebault

M. Partinen, A. Vincent, A. Pollard, 2022 .

Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease in the United Kingdom

Jacqueline Palace, J. Hobart, C. Blain, 2022, JAMA network open.

Predictors of relapse in MOG antibody associated disease: a cohort study

R. Jackson, A. Jacob, R. Kneen, 2021, BMJ Open.

Frequency of MOG-IgG in cerebrospinal fluid versus serum

Jacqueline Palace, S. Irani, A. Handel, 2021, Journal of Neurology, Neurosurgery, and Psychiatry.

Prevalence and incidence of neuromyelitis optica spectrum disorder, aquaporin-4 antibody-positive NMOSD and MOG antibody-positive disease in Oxfordshire, UK

Jacqueline Palace, K. O'Connell, M. Leite, 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

Myelin oligodendrocyte glycoprotein CSF testing needs testing

A. Vincent, P. Waters, 2019, Neurology.

Myelin oligodendrocyte glycoprotein antibodies in neurological disease

M. Reindl, P. Waters, 2018, Nature Reviews Neurology.

Intrathecal Production of MOG-IgG

Wesley T. Kerr, W. Kerr, P. Waters, 2021, Neurology.

Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G in the CSF Clinical Implication of Testing and Association With Disability

Seong-Joon Kim, J. Sung, T. Nam, 2022 .

Paediatric brainstem encephalitis associated with glial and neuronal autoantibodies

A. Vincent, N. Yuki, B. Lang, 2016, Developmental medicine and child neurology.

Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica

A. Vincent, G. Akman-Demir, P. Waters, 2013, Journal of the Neurological Sciences.

Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort

A. Vincent, E. Wassmer, C. Cummins, 2013, Journal of Neurology, Neurosurgery & Psychiatry.

Aquaporin-4 antibody isoform binding specificities do not explain clinical variations in NMO

J. Palace, A. Vincent, M. Leite, 2015, Neurology: Neuroimmunology & Neuroinflammation.

Neutrophil protease inhibition reduces neuromyelitis optica–immunoglobulin G–induced damage in mouse brain

M. Papadopoulos, S. Saadoun, A. Vincent, 2012, Annals of neurology.

Recurrent Optic Neuritis Associated With MOG Antibody Seropositivity

A. Vincent, P. Waters, M. Woodhall, 2017, The neurologist.

International multicenter examination of MOG antibody assays

Jacqueline Palace, K. Rostásy, J. Mills, 2020, Neurology: Neuroimmunology & Neuroinflammation.

Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4

A. Vincent, S. Jarius, A. Jacob, 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies

J. Palace, A. Vincent, M. Leite, 2013, Journal of Neurology, Neurosurgery & Psychiatry.

Serum MOG-IgG in children meeting multiple sclerosis diagnostic criteria

D. Arnold, A. Bar-Or, B. Banwell, 2022, Multiple sclerosis.

A multicenter comparison of MOG-IgG cell-based assays

J. Mills, S. Irani, M. Majed, 2019, Neurology.

A 41-year-old woman with acute weakness and encephalopathy associated with MOG antibodies

Arjune Sen, A. Vincent, M. Leite, 2015, Neurology: Neuroimmunology & Neuroinflammation.

Antibodies to AMPA receptors in Rasmussen's encephalitis.

C. Elger, C. Bien, A. Vincent, 2016, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

The serum metabolomic profile of a distinct, inflammatory subtype of acute psychosis

A. Coles, B. Lennox, F. Probert, 2022, Molecular psychiatry.

Anti-MOG antibodies with longitudinally extensive transverse myelitis preceded by CLIPPERS

M. Symmonds, U. Schulz, M. Leite, 2015, Neurology.

requirements by permitting unilateral optic neuritis or asymptomatic brain MRI lesions

A. Traboulsee, B. Banwell, W. Carroll, 2022 .

Non-radioactive serological diagnosis of myasthenia gravis and clinical features of patients from Tianjin, China

A. Vincent, D. Beeson, L. Clover, 2011, Journal of the Neurological Sciences.

We need to talk about MOG

Jacqueline Palace, P. Waters, 2020, Neurology.

Structural and functional anatomy of the globular domain of complement protein C1q (vol 95, pg 113, 2004)

A. Agrawal, M. Gadjeva, D. Bonifati, 2005 .

Glycine receptor antibody mediated Progressive Encephalomyelitis with Rigidity and Myoclonus (PERM): a rare but treatable neurological syndrome

R. Howard, A. Vincent, R. Chalmers, 2013, Practical Neurology.

Neue serologische Marker zur Differentialdiagnose der Autoimmun-Enzephalitis/New serological markers for the differential diagnosis of autoimmune limbic encephalitis

A. Vincent, J. Dalmau, K. Wandinger, 2011 .

Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype.

M. Jorge Cardoso, Michael R. Johnson, Clive R. Rosenthal, 2013, Brain : a journal of neurology.

Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia

Esther B. E. Becker, A. Vincent, F. Sobott, 2012, Journal of Neurology, Neurosurgery & Psychiatry.

A clinical approach to diagnosis of autoimmune encephalitis

A. Venkatesan, J. Honnorat, K. Rostásy, 2016, The Lancet Neurology.

Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria

Jacqueline Palace, B. Banwell, K. Fujihara, 2023, The Lancet Neurology.

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease

K. Fujihara, Jacqueline A Palace, T. Misu, 2015, Neurology: Neuroimmunology & Neuroinflammation.

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica

A. Vincent, W. Kristoferitsch, A. Vincent, 2008, Brain : a journal of neurology.

Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.

Jacqueline A Palace, A. Vincent, D. Beeson, 2008, Archives of neurology.

NMO-IgG/Aqp4-Ab belongs to the IgG1 subclass and activates complement in vitro

A. Vincent, M. Leite, S. Jarius, 2007 .

Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis

F. Paul, A. Vincent, K. Ruprecht, 2010, Journal of the Neurological Sciences.

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.

M. Papadopoulos, A. Verkman, S. Saadoun, 2010, Brain : a journal of neurology.

N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes

D. Kullmann, C. Bien, A. Vincent, 2010, Brain : a journal of neurology.

NMOSD and MS prevalence in the Indigenous populations of Australia and New Zealand

S. Broadley, A. Kermode, S. Subramanian, 2021, Journal of Neurology.

Paraneoplastic neurologic disorders in small cell lung carcinoma

C. Chapman, A. Vincent, B. Lang, 2015, Neurology.

N‐methyl‐D‐aspartate receptor antibodies in post–herpes simplex virus encephalitis neurological relapse

A. Vincent, A. Siddiqui, Jean-Pierre Lin, 2014, Movement disorders : official journal of the Movement Disorder Society.

Autoantibodies associated with diseases of the CNS: new developments and future challenges

Christian G Bien, C. Bien, A. Vincent, 2011, The Lancet Neurology.

Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis

J. Schott, A. Bleasel, A. Vincent, 2011, Annals of neurology.

Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia

A. Vincent, E. Peles, K. Kleopa, 2010, Brain : a journal of neurology.

Immunoglobulin G antibodies to the N‐Methyl‐D‐aspartate receptor are distinct from immunoglobulin A and immunoglobulin M responses

J. Honnorat, F. Leypoldt, M. Reindl, 2015, Annals of neurology.

Infectious and Autoantibody-Associated Encephalitis: Clinical Features and Long-term Outcome

A. Vincent, E. Tantsis, M. Menezes, 2015, Pediatrics.

Diagnostic use of autoantibodies in myasthenia gravis

A. Vincent, M. Leite, P. Waters, 2010, Autoimmunity.

The search for new antigenic targets in myasthenia gravis

A. Vincent, J. Cossins, D. Beeson, 2012, Annals of the New York Academy of Sciences.

Structural Characterisation of Ligand-Binding Determinants in Human Lung Surfactant Protein D: Influence of Asp325

U. Kishore, A. Shrive, T. Greenhough, 2009, Journal of molecular biology.

C1q and tumor necrosis factor superfamily: modularity and versatility.

Robert B Sim, G. Arlaud, U. Kishore, 2004, Trends in immunology.

Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens

P. Fallon, H. Cross, A. Vincent, 2012, Journal of Neurology, Neurosurgery & Psychiatry.

Autoantibodies to neuronal antigens in children with new‐onset seizures classified according to the revised ILAE organization of seizures and epilepsies

A. Vincent, R. Dale, B. Lang, 2013, Epilepsia.

Disease-relevant autoantibodies in first episode schizophrenia

Peter B. Jones, Sarosh R. Irani, P. McKenna, 2010, Journal of Neurology.

Randomized Placebo‐Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy

J. Britton, S. Irani, S. Pittock, 2019, Annals of neurology.

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS

A. Vincent, K. Park, Sung-Min Kim, 2015, Neurology: Neuroimmunology & Neuroinflammation.

Use of Peptide:HLA Class II Complexes to Study Specific T Cells in Autoimmune Myasthenia Gravis

N. Glaichenhaus, U. Kishore, N. Willcox, 2003, Annals of the New York Academy of Sciences.

C1q and its growing family.

M. Gadjeva, Robert B Sim, K. Reid, 2007, Immunobiology.

Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy

M. Brodie, S. Howell, A. Vincent, 2013, Epilepsia.

Antibodies Produced by CLL Phenotype B Cells in Patients With Myasthenia Gravis Are Not Directed Against Neuromuscular Endplates

B. Becher, F. Sallusto, A. Lanzavecchia, 2023, Neurology: Neuroimmunology & Neuroinflammation.

Passive and active immunization models of MuSK-Ab positive myasthenia: Electrophysiological evidence for pre and postsynaptic defects

A. Vincent, J. Cossins, L. Jacobson, 2012, Experimental Neurology.

Recombinant surfactant protein-D selectively increases apoptosis in eosinophils of allergic asthmatics and enhances uptake of apoptotic eosinophils by macrophages.

U. Kishore, P. Waters, T. Madan, 2008, International immunology.

Investigation of neuronal autoantibodies in two different focal epilepsy syndromes

A. Vincent, B. Lang, C. Gurses, 2014, Epilepsia.

Structural and functional anatomy of the globular domain of complement protein C1q.

A. Agrawal, M. Gadjeva, D. Bonifati, 2004, Immunology letters.

Autoantibodies against Neurologic Antigens in Nonneurologic Autoimmunity

D. Hafler, J. Guthridge, V. Holers, 2019, The Journal of Immunology.

Purification of surfactant protein D (SP-D) from pooled amniotic fluid and bronchoalveolar lavage.

U. Kishore, A. G. Tsolaki, P. Waters, 2014, Methods in molecular biology.

Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis

Yoon-Ho Hong, J. Sung, T. Nam, 2022, Journal of Neurology.

Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis

A. Vincent, S. Irani, L. Jacobson, 2022, Journal of Neurology, Neurosurgery, and Psychiatry.

Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features

Yoon-Ho Hong, J. Sung, Suk-Won Ahn, 2018, PloS one.

Peripheral VH4+ plasmablasts demonstrate autoreactive B cell expansion toward brain antigens in early multiple sclerosis patients

Ann M. Stowe, L. Cowell, E. Meffre, 2016, Acta Neuropathologica.

Myelin-oligodendrocyte glycoprotein antibody-associated disease

O. Ciccarelli, Jacqueline Palace, A. Traboulsee, 2021, The Lancet Neurology.

Distinct HLA associations of LGI1 and CASPR2-antibody diseases

J. Knight, K. Elliott, Arjune Sen, 2018, Brain : a journal of neurology.

Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms

Arjune Sen, R. Bashford-Rogers, D. Anthony, 2020, Brain : a journal of neurology.

The importance of early immunotherapy in patients with faciobrachial dystonic seizures

G. Widman, M. Malter, L. Hirsch, 2017, Brain : a journal of neurology.

Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease

Jacqueline Palace, Y. Kong, Lucy Matthews, 2016, Journal of Neurology, Neurosurgery & Psychiatry.

Isolated new onset ‘atypical’ optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up

Jacqueline A Palace, A. Vincent, M. Leite, 2016, Journal of Neurology.

Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children

Jacqueline A Palace, A. Vincent, M. Tardieu, 2015, Neurology: Neuroimmunology & Neuroinflammation.

Cerebrospinal fluid/serum gradient of IgG is associated with disability at acute attacks of neuromyelitis optica

M. Go, J. Sung, K. Park, 2011, Journal of Neurology.

Chronic neuropathic pain severity is determined by lesion level in aquaporin 4-antibody-positive myelitis

I. Tracey, Y. Kong, Jacqueline A Palace, 2016, Journal of Neurology, Neurosurgery & Psychiatry.

Detection and significance of neuronal autoantibodies in patients with meningoencephalitis in Vientiane, Lao PDR

P. Newton, M. Mayxay, S. Irani, 2022, Transactions of the Royal Society of Tropical Medicine and Hygiene.

MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis

S. Broadley, J. Lechner-Scott, M. Slee, 2021, Frontiers in Neurology.

Spinal cord MRI features in neuromyelitis optica (NMO): characteristics and relationship with severity and recovery in longitudinally extensive transverse myelitis (LETM) attacks

Jacqueline Palace, A. Vincent, M. Leite, 2013 .

Evaluation of aquaporin‐4 antibody assays

B. Weinshenker, J. Bennett, D. Wingerchuk, 2014, Clinical & experimental neuroimmunology.

Significance of Neuronal Autoantibodies in Comparison to Infectious Etiologies among Patients Presenting with Encephalitis in a Region with a High Prevalence of Infections

A. Vincent, J. Wanigasinghe, L. Jacobson, 2022, Annals of Indian Academy of Neurology.

Predictors of outcome in a large retrospective cohort of patients with transverse myelitis

R. Bergamaschi, E. Marchioni, A. Pichiecchio, 2018, Multiple sclerosis.

Bone health in neuromyelitis optica: Bone mineral density and fractures.

H. Choi, J. Sung, S. Kong, 2020, Multiple sclerosis and related disorders.

MRI and laboratory features and the performance of international criteria in the diagnosis of multiple sclerosis in children and adolescents: a prospective cohort study.

D. Arnold, A. Bar-Or, B. Banwell, 2018, The Lancet. Child & adolescent health.

Classifying the antibody-negative NMO syndromes

Jacqueline Palace, D. Anthony, T. Claridge, 2019, Neurology: Neuroimmunology & Neuroinflammation.

Correction: Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features

Yoon-Ho Hong, J. Sung, Suk-Won Ahn, 2018, PloS one.

Antiglycine receptor antibody related disease: a case series and literature review

S. Broadley, A. Vincent, S. Irani, 2018, European Journal of Neurology.

Glycine receptor antibodies in 2 cases of new, adult-onset epilepsy

B. Giometto, A. Vincent, E. Ferlazzo, 2014, Neurology: Neuroimmunology & Neuroinflammation.

Glycine receptor antibodies are detected in progressive encephalomyelitis with rigidity and myoclonus (PERM) but not in saccadic oscillations

A. Vincent, J. Hamada, B. Lang, 2012, Journal of Neurology.

Complement activation in patients with neuromyelitis optica

E. Havrdová, A. Vincent, D. Horáková, 2014, Journal of Neuroimmunology.

Reduced serum uric acid levels in neuromyelitis optica: serum uric acid levels are reduced during relapses in NMO

A. Vincent, P. Waters, J. Min, 2012, Acta neurologica Scandinavica.

Overlapping central and peripheral nervous system syndromes in MOG antibody–associated disorders

S. Broadley, M. Barnett, S. Irani, 2020, Neurology: Neuroimmunology & Neuroinflammation.

Incidence and prevalence of NMOSD in Australia and New Zealand

K. Dear, S. Broadley, J. Lechner-Scott, 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

Neuronal antibodies in pediatric epilepsy: Clinical features and long‐term outcomes of a historical cohort not treated with immunotherapy

H. Stroink, A. Vincent, O. Brouwer, 2016, Epilepsia.

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica

P. Trillenberg, X. Montalban, F. Paul, 2016, Journal of Neurology, Neurosurgery & Psychiatry.

Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies

K. Fujihara, T. Misu, M. Sepúlveda, 2016, Journal of Neurology, Neurosurgery & Psychiatry.

Leucine‐Rich Glioma‐Inactivated 1 versus Contactin‐Associated Protein‐like 2 Antibody Neuropathic Pain: Clinical and Biological Comparisons

D. Bennett, S. Irani, R. Dale, 2021, Annals of neurology.

Acquired neuromyotonia in thymoma‐associated myasthenia gravis: a clinical and serological study

E. Marchioni, A. Vincent, R. Furlan, 2019, European journal of neurology.

Leucine‐Rich Glioma‐Inactivated 1 versus Contactin‐Associated Protein‐like 2 Antibody Neuropathic Pain: Clinical and Biological Comparisons

S. Irani, R. Dale, J. Varley, 2021, Annals of Neurology.

Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G in the CSF

J. Sung, T. Nam, Sung-Hye Park, 2021, Neurology: Neuroimmunology & Neuroinflammation.

Comparison of Spinal Cord Magnetic Resonance Imaging Features Among Children With Acquired Demyelinating Syndromes

D. Arnold, A. Bar-Or, B. Banwell, 2021, JAMA Network Open.

Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating Diseases

Jacqueline Palace, S. Vukusic, A. Lutterotti, 2021, Neurology: Neuroimmunology & Neuroinflammation.

Silent New Brain MRI Lesions in Children with MOG‐Antibody Associated Disease

A. Bar-Or, B. Banwell, R. Marrie, 2020, Annals of neurology.

Cell-based assays for the detection of MOG antibodies: a comparative study

M. Versino, L. Benedetti, T. Foiadelli, 2020, Journal of Neurology.

AQP4 Antibody Assay Sensitivity Comparison in the Era of the 2015 Diagnostic Criteria for NMOSD

S. Broadley, A. Vincent, M. Barnett, 2019, Front. Neurol..

Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies

Seong-Joon Kim, S. Irani, Sung-Min Kim, 2018, Journal of Neuroinflammation.

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort

A. Traboulsee, M. Fritzler, R. Carruthers, 2021, Frontiers in Neurology.

Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G

J. Sung, K. Park, K. Jung, 2017, Multiple sclerosis.

Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis

F. Piehl, S. Cervenka, S. Irani, 2021, Translational Psychiatry.

Recombinant forms of monomeric and homotrimeric globular regions of human C1q as inhibitors of complement and microglia activation induced by beta-amyloid and familial dementia peptides

M. Gadjeva, J. Ferluga, Robert B Sim, 2010 .

Clinical features which predict neuronal surface autoantibodies in new-onset focal epilepsy: implications for immunotherapies

Arjune Sen, S. Howell, J. Adcock, 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

Serum MOG-IgG titers should be performed routinely in the diagnosis and follow-up of MOGAD: No.

P. Waters, E. Flanagan, 2023, Multiple Sclerosis.

Characterization of the spectrum of Korean inflammatory demyelinating diseases according to the diagnostic criteria and AQP4-Ab status

J. Sung, K. Park, Sung-Min Kim, 2014, BMC Neurology.

Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders

J. Sung, K. Park, Sung-Min Kim, 2013, Multiple sclerosis.

Revised Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorders (S63.001)

A. Traboulsee, B. Banwell, W. Carroll, 2014 .

Rituximab abrogates aquaporin-4–specific germinal center activity in patients with neuromyelitis optica spectrum disorders

Jacqueline Palace, Anne-Kathrin Kienzler, S. Irani, 2022, Proceedings of the National Academy of Sciences of the United States of America.

Prospective characterization of children positive for anti-MOG antibodies meeting Multiple Sclerosis diagnostic criteria

D. Arnold, A. Bar-Or, B. Banwell, 2019 .

Detection of NMDARs Antibodies in Encephalitis.

A. Vincent, P. Waters, M. Gastaldi, 2017, Methods in molecular biology.

Neutrophil protease inhibition reduces NMO-IgG-induced damage in mouse brain

M. Papadopoulos, A. Verkman, S. Saadoun, 2011 .

Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply.

Jacqueline A Palace, A. Vincent, P. Waters, 2014, JAMA neurology.

GABAA receptor autoimmunity

M. Geschwind, J. Gelfand, V. Lennon, 2019, Neurology: Neuroimmunology & Neuroinflammation.

A feline model of spontaneously occurring autoimmune limbic encephalitis.

S. Irani, B. Lang, S. Kneissl, 2023, Veterinary journal.

Assessment of aquaporin-4 (AQP4) antibody assays in European diagnostic centres

Jacqueline Palace, F. Paul, B. Giometto, 2014, Journal of Neuroimmunology.

Antibodies to GABAA receptor α1 and γ2 subunits

A. Vincent, J. Coebergh, S. Irani, 2015, Neurology.

G2A1B3AA receptor antibodies and their clinical associations

S. Irani, P. Waters, 2017, Neurology.

Neurexin-3α

S. Irani, P. Waters, 2016, Neurology.

Pathogenic potential of antibodies to the GABAB receptor

E. Mann, D. Kullmann, A. Vincent, 2017, Epilepsia open.

Progressive Encephalomyelitis with Rigidity and Myoclonus: A Syndrome with Diverse Clinical Features and Antibody Responses

A. Vincent, M. Leite, P. Waters, 2013, European Neurology.

Antibodies to Components of the Voltage-Gated Potassium Channel - Associated Complex: LGI1 and CASPR2 as Antigenic Targets in Limbic Encephalitis, Morvan's and Neuromyotonia

A. Vincent, K. Kleopa, S. Irani, 2010 .

Progressive encephalomyelitis with rigidity and myoclonus: a syndrome with diverse clinical features and antibody responses.

A. Vincent, M. Leite, P. Waters, 2013 .

Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype

M. Jorge Cardoso, Michael R. Johnson, N. Voets, 2013 .

LONG TERM OUTCOME IN NEUROMYELITIS OPTICA: LESSONS FROM 6 YEARS OF THE UK NMO STUDY

J. Palace, E. Silber, T. Solomon, 2009 .

Do Early Relapses Predict the Risk of Long‐Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD?

Jacqueline Palace, J. Hobart, C. Blain, 2023, Annals of neurology.

Autoantibodies to neuronal antigens in children with new‐onset seizures classified according to the revised ILAE organization of seizures and epilepsies

R. Dale, B. Lang, D. Gill, 2013, Epilepsia.

Progressive encephalomyelitis with rigidity and myoclonus: the first pediatric case with glycine receptor antibodies.

E. Coutinho, M. Leite, P. Waters, 2013, JAMA neurology.

Investigation of neuronal autoantibodies in two different focal epilepsy syndromes

B. Lang, C. Gurses, N. Bebek, 2014, Epilepsia.

Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype.

M. Jorge Cardoso, Michael R. Johnson, Emily N. Manning, 2013, Brain : a journal of neurology.

Detection methods for neural autoantibodies.

B. Lang, P. Waters, Philippa Pettingill, 2016, Handbook of clinical neurology.

PROGRESSIVE ENCEPHALOMYELITIS, RIGIDITY, AND MYOCLONUS: A NOVEL GLYCINE RECEPTOR ANTIBODY

Michael K. Hutchinson, C. Becker, S. O'Riordan, 2008, Neurology.

Paraneoplastic neurologic disorders in small cell lung carcinoma

C. Chapman, B. Lang, P. Waters, 2015, Neurology.

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.

M. Papadopoulos, A. Verkman, S. Saadoun, 2010, Brain : a journal of neurology.

Antibodies identified by cell‐based assays in myasthenia gravis and associated diseases

J. Cossins, D. Beeson, L. Jacobson, 2012, Annals of the New York Academy of Sciences.

Pregnancy outcomes in aquaporin-4–positive neuromyelitis optica spectrum disorder

T. Misu, M. Leite, I. Nakashima, 2016, Neurology.

Non-radioactive serological diagnosis of myasthenia gravis and clinical features of patients from Tianjin, China

D. Beeson, L. Clover, Li Yang, 2011, Journal of the Neurological Sciences.

Neuropathic Pain: Clinical and Biological Comparisons

David L. Bennett, S. Irani, R. Dale, 2021 .